1. Tari A,King 美国 Harvard University Evolution of HER2 expression between pre-treatment biopsy and residual disease after neoadjuvant the..
2. Elizabeth A,Mittendorf 美国 University of Texas MD Anderson Cancer Center Evolution of HER2 expression between pre-treatment biopsy and residual disease after neoadjuvant the..
3. Giuseppe,Curigliano 意大利 University of Milan Evolution of HER2 expression between pre-treatment biopsy and residual disease after neoadjuvant the..
4. Nancy U,Lin 美国 Harvard University Evolution of HER2 expression between pre-treatment biopsy and residual disease after neoadjuvant the..
5. Sara M,Tolaney 美国 Harvard University Evolution of HER2 expression between pre-treatment biopsy and residual disease after neoadjuvant the..
6. Myung-Shik,Lee 韩国 Yonsei University ANXA2 (annexin A2) is crucial to ATG7-mediated autophagy, leading to tumor aggressiveness in triple-..
7. Aree,Moon 韩国 DUKSUNG WOMENS University ANXA2 (annexin A2) is crucial to ATG7-mediated autophagy, leading to tumor aggressiveness in triple-..
8. 杨金铭 美国 PENN STATE University Targeting lncRNA DDIT4-AS1 Sensitizes Triple Negative Breast Cancer to Chemotherapy via Suppressing ..
9. 胡夕春 中国 复旦大学上海医学院 Incidence and prognostic significance of receptor discordance between primary breast cancer and pair..
10. Emad A,Rakha 英国 University of Nottingham UK recommendations for HER2 assessment in breast cancer: an update
11. Puay Hoon,Tan 新加坡 Singapore General Hospital UK recommendations for HER2 assessment in breast cancer: an update
12. Ian O,Ellis 英国 University of Nottingham UK recommendations for HER2 assessment in breast cancer: an update
13. Pinder, Sarah E. 英国 Kings College London UK recommendations for HER2 assessment in breast cancer: an update
14. Marcus,Schmidt 德国 Johannes Gutenberg University Mainz Discordance of HER2-Low between Primary Tumors and Matched Distant Metastases in Breast Cancer
15. Giuseppe,Curigliano 意大利 University of Milan 'Why is survival with triple negative breast cancer so low? insights and talking points from preclin..
16. Frederique,Penault-Llorca 法国 University of AUVERGNE Circulating proteins as predictive and prognostic biomarkers in breast cancer
17. 邵志敏 中国 复旦大学上海医学院 SDF-1 expression and tumor-infiltrating lymphocytes identify clinical subtypes of triple-negative br..
18. Sapino, Anna 意大利 University of TURIN Unusual Patterns of HER2 Expression in Breast Cancer: Insights and Perspectives
19. Nadia,Harbeck 德国 University of MUNICH Hormone Receptor and HER2 Status Switch in Non-pCR Breast Cancer Specimens after Neoadjuvant Therapy
20. Lollini, Pier-Luigi 意大利 University of Bologna Prevention and Therapy of Metastatic HER-2+ Mammary Carcinoma with a Human Candidate HER-..